88 results
8-K
EX-99.1
IDYA
Ideaya Biosciences Inc
7 May 24
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results
6:04am
such as the MAT2A inhibitor IDE397 which targets MTAP-deleted solid tumors and PARG inhibitor IDE161 which targets HRD solid tumors, both continue … Programs
Early preclinical research programs focused on pharmacological inhibition of several new targets for patients with solid tumors characterized
8-K
EX-99.1
IDYA
Ideaya Biosciences Inc
12 Mar 24
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
6:04am
, in patients with MSI-high and MSS endometrial cancer
Potential first-in-class PARG inhibitor, in combination with anti-PD-1 therapy, targets two … capabilities to synthetic lethality – which represents an emerging class of precision medicine targets.
Forward-Looking Statements
This press release
8-K
EX-99.1
b6t9 9olxypww
20 Feb 24
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023
6:07am
424B5
4nxgzqqv2uxuk
19 Jan 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
8ynb648ijc4w37wdji9z
4 Dec 23
IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer
6:04am
8-K
EX-99.1
sfb 7w04lq
7 Nov 23
IDEAYA Biosciences, Inc. Reports Third Quarter 2023
6:01am
424B5
a6236zl2
25 Oct 23
Prospectus supplement for primary offering
9:45pm
424B5
4ek9spgytcinff
24 Oct 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
e1ysrryvf7hpb799m
10 Aug 23
IDEAYA Biosciences, Inc. Reports Second Quarter 2023
6:01am
424B5
g2tc9gqfrr0w
26 Jun 23
Prospectus supplement for primary offering
5:30pm
8-K
EX-99.1
6ifqbbh1afah8 6cmuaq
16 May 23
IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
6:02am
8-K
EX-99.1
tf65fopozfu 3y2
9 May 23
IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results
6:01am
424B5
4d9 492rdwwdaouovg
25 Apr 23
Prospectus supplement for primary offering
7:35pm